Inge Scharrer

445 total citations
8 papers, 344 citations indexed

About

Inge Scharrer is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Inge Scharrer has authored 8 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 6 papers in Immunology and 1 paper in Surgery. Recurrent topics in Inge Scharrer's work include Complement system in diseases (6 papers), Platelet Disorders and Treatments (5 papers) and Blood groups and transfusion (4 papers). Inge Scharrer is often cited by papers focused on Complement system in diseases (6 papers), Platelet Disorders and Treatments (5 papers) and Blood groups and transfusion (4 papers). Inge Scharrer collaborates with scholars based in Germany, Netherlands and Switzerland. Inge Scharrer's co-authors include Charis von Auer, Martina Böhm, Constance C. F. M. J. Baaten, Judith M.E.M. Cosemans, Tom G. Mastenbroek, Richard W. Farndale, Nicholas Pugh, Barbara Zieger, Frauke Swieringa and Johan W. M. Heemskerk and has published in prestigious journals such as Nature Communications, Blood and British Journal of Haematology.

In The Last Decade

Inge Scharrer

8 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inge Scharrer Germany	6	239	129	76	72	70	8	344
Seb Lamprecht Belgium	9	321 1.3×	250 1.9×	108 1.4×	91 1.3×	101 1.4×	12	497
Henk Louwes Netherlands	8	358 1.5×	40 0.3×	49 0.6×	87 1.2×	44 0.6×	14	448
J Diéval France	7	298 1.2×	35 0.3×	18 0.2×	59 0.8×	48 0.7×	20	381
Josephine P. Ferrel United States	9	334 1.4×	45 0.3×	14 0.2×	157 2.2×	58 0.8×	10	394
Verónica Palma‐Barqueros Spain	10	212 0.9×	48 0.4×	13 0.2×	53 0.7×	30 0.4×	15	288
Jelle Adelmeijer Netherlands	6	285 1.2×	48 0.4×	11 0.1×	39 0.5×	56 0.8×	9	400
Giovanna Scenna Italy	7	100 0.4×	80 0.6×	14 0.2×	71 1.0×	19 0.3×	8	297
DJ Kuter United States	7	448 1.9×	30 0.2×	18 0.2×	126 1.8×	125 1.8×	9	487
Akinobu Funatsu Japan	11	263 1.1×	28 0.2×	11 0.1×	63 0.9×	69 1.0×	22	354
T. Tison Italy	8	109 0.5×	98 0.8×	31 0.4×	133 1.8×	9 0.1×	19	281

Countries citing papers authored by Inge Scharrer

Since Specialization

Citations

This map shows the geographic impact of Inge Scharrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Scharrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Scharrer more than expected).

Fields of papers citing papers by Inge Scharrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Scharrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Scharrer. The network helps show where Inge Scharrer may publish in the future.

Co-authorship network of co-authors of Inge Scharrer

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Scharrer. A scholar is included among the top collaborators of Inge Scharrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Scharrer. Inge Scharrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Swieringa, Frauke, Rachel Cavill, Roger van Kruchten, et al.. (2014). Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nature Communications. 5(1). 4257–4257. 184 indexed citations

2.

Falter, Tanja, et al.. (2010). Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.. Blood. 116(21). 3678–3678. 1 indexed citations

3.

Falter, Tanja, et al.. (2010). ADAMTS13 In 4 Different VWF/VIII Concentrates and Its Impact on Therapy.. Blood. 116(21). 3677–3677. 1 indexed citations

4.

Auer, Charis von, et al.. (2007). Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia. Thrombosis and Haemostasis. 97(2). 228–233. 45 indexed citations

5.

Kasper, Stefan, Markus F. Neurath, Christoph Huber, Matthias Theobald, & Inge Scharrer. (2007). Protein A immunoadsorption therapy for refractory, mitomycin C–associated thrombotic microangiopathy. Transfusion. 47(7). 1263–1267. 12 indexed citations

6.

Böhm, Martina, Christoph Betz, Wolfgang Miesbach, et al.. (2005). The course of ADAMTS‐13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. British Journal of Haematology. 129(5). 644–652. 64 indexed citations

7.

Böhm, Martina, et al.. (2003). ADAMTS-13 activity in patients with brain and prostate tumors is mildly reduced, but not correlated to stage of malignancy and metastasis. Thrombosis Research. 111(1-2). 33–37. 25 indexed citations

8.

Budde, Ulrich, et al.. (1995). The Thrombostat 4000 A Sensitive Screening Test for von Willebrand's Disease. Seminars in Thrombosis and Hemostasis. 21(S 02). 44–51. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact